Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
28.4M
-
Shares change
-
+28.4M
-
Total reported value, excl. options
-
$581M
-
Value change
-
+$581M
-
Number of buys
-
47
-
Price
-
$21.00
Significant Holders of Generation Bio Co. - #OTHER (GBIO) as of Q2 2020
48 filings reported holding GBIO - Generation Bio Co. - #OTHER as of Q2 2020.
Generation Bio Co. - #OTHER (GBIO) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.4M shares
of 67M outstanding shares and own 42.32% of the company stock.
Largest 10 shareholders include FMR LLC (7.37M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.18M shares), Artal Group S.A. (2.81M shares), FARALLON CAPITAL MANAGEMENT LLC (2.12M shares), WELLINGTON MANAGEMENT GROUP LLP (2.07M shares), Casdin Capital, LLC (1.61M shares), Bellevue Group AG (1.44M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.19M shares), Foresite Capital Management IV, LLC (858K shares), and VICTORY CAPITAL MANAGEMENT INC (849K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.